Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

HUTCHMED (China) (HCM) Receivables (2016 - 2025)

Historic Receivables for HUTCHMED (China) (HCM) over the last 12 years, with Q2 2025 value amounting to $168.5 million.

  • HUTCHMED (China)'s Receivables fell 184.35% to $168.5 million in Q2 2025 from the same period last year, while for Jun 2025 it was $168.5 million, marking a year-over-year decrease of 184.35%. This contributed to the annual value of -$41.8 million for FY2024, which is 10027.94% down from last year.
  • According to the latest figures from Q2 2025, HUTCHMED (China)'s Receivables is $168.5 million, which was down 184.35% from $20.0 billion recorded in Q4 2024.
  • Over the past 5 years, HUTCHMED (China)'s Receivables peaked at $20.0 billion during Q4 2024, and registered a low of -$41.2 million during Q4 2021.
  • Moreover, its 5-year median value for Receivables was $154.3 million (2022), whereas its average is $3.6 billion.
  • Per our database at Business Quant, HUTCHMED (China)'s Receivables plummeted by 18842.25% in 2021 and then surged by 6109021.11% in 2023.
  • Quarter analysis of 5 years shows HUTCHMED (China)'s Receivables stood at -$41.2 million in 2021, then skyrocketed by 159.3% to $24.4 million in 2022, then surged by 61090.21% to $15.0 billion in 2023, then skyrocketed by 33.71% to $20.0 billion in 2024, then plummeted by 99.16% to $168.5 million in 2025.
  • Its Receivables was $168.5 million in Q2 2025, compared to $20.0 billion in Q4 2024 and $171.6 million in Q2 2024.